Merck, GE17-0180-01, DEAE-Sephadex®A-50

General description
DEAE Sephadex® A-50 is a weak anion exchanger based on the well documented and well proven Sephadex® base matrix and widely used especially in plasma fractionation applications.
thyroglobulin (Mr 669 000)- 2 mg/ml drained medium), HSA (Mr 68 000)- 110 mg/ml drained medium), α-lactalbumin (Mr 14 300)- 50 mg/ml drained medium)
Application
Sephadex® ion exchangers are produced by introducing functional groups onto the cross-linked Dextran matrix. These groups are attached to glucose units in the matrix by stable ether linkages.

Different types of ion exchangers (DEAE, QAE and CM) and two different porosities (A-25/C-25 and A-50/C-50) are available.
Features and Benefits
Weak anion exchanger suitable batch techniques.
High binding capacities.
Well-proven and widely used especially in approved plasma fractionation processes.

Preparation Note
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
Store at 4 to 30 °C (4 to 8, Used Media 20% Ehtanol or 0.01 M NaOH)
Analysis Note
To view the Certificate of Analysis for this product, please visit www.cytiva.com.
Legal Information
DEAE Sephadex is a registered trademark of Cytiva
Sephadex is a registered trademark of Cytiva